Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin plus CBT-I for Insomnia Disorder
NCT02798367Phase 3Unknown
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Mar 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in insomnia disorder, sponsored by Aché Laboratórios Farmacêuticos. Status: unknown.
02
Drugs
melatonin
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT02798367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798367.